Rapid-onset massive immune-mediated pericardial effusion in a patient with anti-IFN-γ autoantibodies syndrome
Abstract
Background: Anti-interferon-gamma (IFN-γ) autoantibodies (AIGAs) syndrome is an emerging adult-onset immunodeficiency (AOID) associated with opportunistic infections and immune dysregulation. Pericardial effusion as a direct manifestation of this syndrome is rarely reported.
Case presentation: A 46-year-old man with a history of Talaromyces marneffei (TM) infection and clinically suspected pulmonary nontuberculous mycobacterial (NTM) disease presented with rapid-onset massive pericardial effusion. The NTM diagnosis was not microbiologically confirmed, as the patient declined bronchoscopy. Pericardial fluid analysis revealed a high inflammatory cell count and an anti-IFN-γ autoantibody titer of 1:2500, identical to serum, despite a negative microbiological workup and no definitive evidence of malignancy on available cytological evaluation. The patient responded well to corticosteroids and anti-NTM therapy, with complete resolution of effusion.
Conclusion: This case highlights pericardial effusion as a potential immune-mediated complication of AIGAs syndrome. Clinicians should consider this diagnosis in patients with unexplained serositis and a history of opportunistic infections.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.